DYN
Price
$17.77
Change
-$0.49 (-2.68%)
Updated
Jan 9 closing price
Capitalization
2.93B
46 days until earnings call
Intraday BUY SELL Signals
ELVN
Price
$26.00
Change
+$2.75 (+11.83%)
Updated
Jan 9 closing price
Capitalization
1.54B
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DYN vs ELVN

Header iconDYN vs ELVN Comparison
Open Charts DYN vs ELVNBanner chart's image
Dyne Therapeutics
Price$17.77
Change-$0.49 (-2.68%)
Volume$1.32M
Capitalization2.93B
Enliven Therapeutics
Price$26.00
Change+$2.75 (+11.83%)
Volume$5.79M
Capitalization1.54B
DYN vs ELVN Comparison Chart in %
DYN
Daily Signal:
Gain/Loss:
ELVN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DYN vs. ELVN commentary
Jan 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and ELVN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 11, 2026
Stock price -- (DYN: $17.77 vs. ELVN: $26.00)
Brand notoriety: DYN and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 47% vs. ELVN: 600%
Market capitalization -- DYN: $2.93B vs. ELVN: $1.54B
DYN [@Biotechnology] is valued at $2.93B. ELVN’s [@Biotechnology] market capitalization is $1.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.28B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileELVN’s FA Score has 1 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • ELVN’s FA Score: 1 green, 4 red.
According to our system of comparison, both DYN and ELVN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 3 TA indicator(s) are bullish while ELVN’s TA Score has 5 bullish TA indicator(s).

  • DYN’s TA Score: 3 bullish, 6 bearish.
  • ELVN’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а -3.95% price change this week, while ELVN (@Biotechnology) price change was +67.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.51%. For the same industry, the average monthly price growth was -0.31%, and the average quarterly price growth was +46.61%.

Reported Earning Dates

DYN is expected to report earnings on Feb 26, 2026.

ELVN is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+3.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($2.93B) has a higher market cap than ELVN($1.54B). ELVN YTD gains are higher at: 68.831 vs. DYN (-9.151). ELVN has higher annual earnings (EBITDA): -111.97M vs. DYN (-445.29M). DYN has more cash in the bank: 792M vs. ELVN (478M). ELVN has less debt than DYN: ELVN (387K) vs DYN (120M). DYN (0) and ELVN (0) have equivalent revenues.
DYNELVNDYN / ELVN
Capitalization2.93B1.54B190%
EBITDA-445.29M-111.97M398%
Gain YTD-9.15168.831-13%
P/E RatioN/AN/A-
Revenue00-
Total Cash792M478M166%
Total Debt120M387K31,008%
FUNDAMENTALS RATINGS
ELVN: Fundamental Ratings
ELVN
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYNELVN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signal:
Gain/Loss:
ELVN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GRHAX20.330.18
+0.89%
Goehring & Rozencwajg Resources Retail
DDFIX18.770.14
+0.75%
Invesco Diversified Dividend R5
ACLCX8.020.01
+0.12%
American Century Value C
NGJFX19.390.02
+0.10%
Nuveen Global Real Estate Securities R6
VGHRX52.170.04
+0.08%
Voya Global High Dividend Low Vol R6

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-2.68%
RNA - DYN
59%
Loosely correlated
N/A
IDYA - DYN
55%
Loosely correlated
+2.61%
XNCR - DYN
55%
Loosely correlated
-2.11%
SYRE - DYN
53%
Loosely correlated
+1.56%
NRIX - DYN
50%
Loosely correlated
+3.60%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with MLTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+11.83%
MLTX - ELVN
44%
Loosely correlated
+28.94%
TERN - ELVN
42%
Loosely correlated
-6.06%
DNLI - ELVN
42%
Loosely correlated
+0.06%
DYN - ELVN
42%
Loosely correlated
-2.68%
WVE - ELVN
41%
Loosely correlated
-6.68%
More